Cash App vs Genome
Torn between Cash App and Genome? The comparison below is built from the same test data we use across the rest of the site.
Both issue on Visa; verification is ID only at Cash App versus ID + proof at Genome; only Cash App takes crypto top-ups.
Cash App is the more cost-effective option for everyday spending and travel thanks to its free virtual cards, no monthly fee, no top-up fee. Genome is the better fit for power users who need ad spend and AI subscriptions.
Where they split
| Field | Cash App | Genome |
|---|---|---|
| Card network | Visa | Visa |
| Card type | Fintech Wallet | Digital Bank / Neobank |
| KYC | ID only | ID + proof |
| Card issuance fee | Free | Virtual card 1 EUR (first 10); 10 EUR from 11th |
| Monthly fee | Free | Free EUR (card monthly fee); non-EEA personal account 20 EUR/mo or 200 EUR/yr |
| Top-up fee | — | Non-Genome card top-up 3% (externally initiated 1%) |
| FX fee | 3% | Non-card currency transactions 2%; EUR/USD/GBP conversion 1% |
| Crypto funding | Yes | No |
| AI tool support | — | ChatGPT |
| Risk level | Low | Medium |
| Our rating | 8.7 | 9.3 |
| User reviews | 592 | 159 |
| Best for | Streaming · App Store / Play | Ad spend · AI subscriptions |
A green left edge marks the side that holds the advantage on that row, where the data gives one.
What sets them apart
- Budget-led users will lean to Cash App: the running cost is the lower of the two.
- Genome covers a wider spread of use cases; Cash App is more of a single-purpose tool.
- Cash App asks for less verification up front, which matters if you want a card live the same day.
- Cash App can sit on a crypto balance; Genome cannot, so the call depends on how you fund it.
- Genome edged Cash App on our composite rating across fees, risk and merchant tests.
- Cash App carries the lower risk flag in our file, which some users prefer for a primary card.
The short version of the matchup
Both cards clear the same checkouts in our tests, so the call comes down to cost. Cash App is cheaper on issuance (free) and top-ups (no top-up fee), while Genome is worth the premium only for ad-platform billing and AI subscriptions.
Questions people ask
That depends on what you spend on. Cash App scores 8.7/10 against Genome's 9.3/10 in our tests, but the two split on fees, KYC and crypto funding. Read the table above, then match it to the checkouts you actually run.
Cash App works out cheaper: no virtual card issuance fee, free account maintenance, no top-up fee. Genome adds about $1.09 per virtual card, a 2% FX fee, a 3% top-up fee.
Cash App asks for ID only at signup; Genome asks for ID + proof. If a light sign-up is the priority, the one with the lower KYC label is the faster route.
Both show up in 8 of the same test scenarios, including Netflix, Hulu, Paramount+. They overlap on a good share of checkouts, so the choice between them matters most on those pages. Where one is accepted and the other is not usually comes down to the billing country and 3-D Secure handling.
Where both show up
Cash App and Genome both landed in our top picks for 8 checkouts. Grouped by category so you can jump straight to the one you actually pay for:
📺 Streaming & Entertainment 5
🛍️ Cross-border Shopping 2
🧳 Travel & Productivity 1
Their BIN ranges
Cards issued in 🇺🇸 US · 🇦🇺 Australia — the country guides group every range we track from there.
What our charge log shows
Every count here is a real charge attempt we placed on that range, renewals included, with the gateway response recorded. Weeks tracked is how long the range has been in the programme: